1. Home
  2. BFC vs COLL Comparison

BFC vs COLL Comparison

Compare BFC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFC
  • COLL
  • Stock Information
  • Founded
  • BFC 1894
  • COLL 2002
  • Country
  • BFC United States
  • COLL United States
  • Employees
  • BFC N/A
  • COLL N/A
  • Industry
  • BFC Major Banks
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFC Finance
  • COLL Health Care
  • Exchange
  • BFC Nasdaq
  • COLL Nasdaq
  • Market Cap
  • BFC 990.6M
  • COLL 910.2M
  • IPO Year
  • BFC N/A
  • COLL 2015
  • Fundamental
  • Price
  • BFC $106.30
  • COLL $27.01
  • Analyst Decision
  • BFC Hold
  • COLL Strong Buy
  • Analyst Count
  • BFC 1
  • COLL 5
  • Target Price
  • BFC $111.00
  • COLL $43.60
  • AVG Volume (30 Days)
  • BFC 30.1K
  • COLL 500.0K
  • Earning Date
  • BFC 04-15-2025
  • COLL 05-08-2025
  • Dividend Yield
  • BFC 1.69%
  • COLL N/A
  • EPS Growth
  • BFC N/A
  • COLL 43.56
  • EPS
  • BFC 6.82
  • COLL 1.86
  • Revenue
  • BFC $163,459,000.00
  • COLL $631,449,000.00
  • Revenue This Year
  • BFC $11.44
  • COLL $19.96
  • Revenue Next Year
  • BFC $6.64
  • COLL $3.93
  • P/E Ratio
  • BFC $15.58
  • COLL $14.55
  • Revenue Growth
  • BFC N/A
  • COLL 11.41
  • 52 Week Low
  • BFC $74.95
  • COLL $23.23
  • 52 Week High
  • BFC $110.49
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • BFC 62.55
  • COLL 43.16
  • Support Level
  • BFC $98.00
  • COLL $23.23
  • Resistance Level
  • BFC $108.12
  • COLL $27.57
  • Average True Range (ATR)
  • BFC 3.71
  • COLL 1.45
  • MACD
  • BFC 0.78
  • COLL -0.08
  • Stochastic Oscillator
  • BFC 83.13
  • COLL 51.82

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: